论文部分内容阅读
Background Endothelial progenitor cells (EPCs) therapy represents a novel strategy for a variety of diseases.Interestingly, spleen acts an important reservoir during EPCs trafficking.Therefore, we investigate the involvement of SDF-1/CXCR4 in EPCs settlement in spleen.